Aryl halides are important chemical components in organic
syntheses.
Herein, we report visible-light-induced, single nickel-catalyzed halogen
exchange of aromatic halides with the corresponding halide salts under
mild conditions. Varieties of aryl iodides, bromides, and chlorides
can smoothly undergo aromatic Finkelstein or retro-Finkelstein reactions with good functional group tolerance. Experimentally,
mechanistic studies showed that excited-state NiII complexes
for facile reductive elimination to form carbon–halide bonds
were involved in the process of Finkelstein and retro-Finkelstein reactions.
Transition-metal-free,
sulfur-mediated allylic C–H arylation,
epoxidation, and aziridination were realized through one-pot procedures.
The reaction design involved initial addition between olefins and
triflic anhydride activated sulfoxides, followed by subsequent reactions
of the allylic sulfur ylides generated under basic conditions with
arylboronic acids, aldehydes, or aldimines, to give allylic arylation,
epoxidation, or aziridination products, respectively.
Herein, we report visible light‐promoted single nickel catalysis for diverse carbon–heteroatom couplings under mild conditions. This mild, general, and robust method to couple diverse nitrogen, oxygen, and sulfur nucleophiles with aryl(heteroaryl)/alkenyl iodides/bromides exhibits a wide functional group tolerance and is applicable to late‐stage modification of pharmaceuticals and natural products. On the base of preliminary mechanistic studies, a NiI/NiIII cycle via the generation of active NiI complexes that appear from homolysis of NiII−I rather than NiII−aryl bond was tentatively proposed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.